Similarly, there we no statistically significant differences between overall survival of melanoma patients stratified by low and high expression of MTNR1A (107.40 vs. 68.09, p = 0.1301) and MTNR1B (93.01 vs. 72.06, p = 0.5898). The gene discussed is MTNR1A; the disease is melanoma.